Cambridge, MA, United States of America

Deborah Pallister


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations and Contributions of Deborah Pallister

Introduction

Deborah Pallister is a notable inventor based in Cambridge, MA (US). She has made significant contributions to the field of biomedical research, particularly in the area of immunology. Her work focuses on innovative methods for inducing immune responses, which have important implications for treating various diseases.

Latest Patents

Deborah Pallister holds a patent titled "Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent." This invention relates to a method of inducing a CD8 CTL response in individuals deficient in CD4 T cells. The patent outlines a process of administering a heat shock protein or a portion of an ATP binding domain of a heat shock protein joined to a molecule. This method is particularly relevant for treating HIV in individuals lacking CD4 T cells. Additionally, the invention encompasses methods for inducing a CD4-independent CTL response and includes a composition characterized by a portion of an ATP binding domain of a heat shock protein joined to a molecule.

Career Highlights

Throughout her career, Deborah Pallister has worked with prestigious institutions such as the Whitehead Institute for Biomedical Research and the Massachusetts Institute of Technology. Her research has contributed to advancements in understanding immune responses and developing therapeutic strategies.

Collaborations

Deborah has collaborated with esteemed colleagues, including Qian Huang and Joan F. L. Richmond. These collaborations have further enriched her research and expanded the impact of her inventions.

Conclusion

Deborah Pallister's innovative work in immunology and her patent contributions highlight her role as a significant figure in biomedical research. Her methods for inducing immune responses have the potential to transform treatment approaches for individuals with specific immune deficiencies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…